drugset / Trial / NCT03990597

StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord

NCT03990597

NaSingle-groupOpen-labelSupportive care

Summary

This phase I trial studies the side effects of a silicone topical wound dressing (StrataXRT) and to see how well it works in preventing radiation dermatitis (skin burns and side effects caused by radiation) in pediatric patients undergoing radiation therapy. StrataXRT may help prevent or decrease severe skin rash, pain, itching, skin peeling, and dry skin in pediatric patients undergoing radiation therapy to the brain or spinal cord.

Timeline

Start
2019-08-19
Primary completion
2020-11-24
Completion
2020-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject StrataXRT Other / unclassified Topical